09:48 AM EST - MedX Health Corp. : Announced that it has partnered with OncoTech LLC, a U.S.-based company, to develop the market for MedX's SIAscopy products in Mexico, Colombia and Spain, as well as selected developing countries. OncoTech will immediately begin working on obtaining regulatory approval for SIAscopy in Mexico and Colombia as well as working with its local networks to launch SIAscopy. Since SIAscopy is already CE approved, OncoTech will begin developing a marketing plan for SIAscopy in Spain. MedX Health Corp.
shares V.MDX are trading unchanged at $0.13.
